Loading…

Flash Player 9 (or above) is needed to view presentations.
We have detected that you do not have it on your computer. To install it, go here.

Like this document? Why not share!

Excellence in research

on

  • 970 views

 

Statistics

Views

Total Views
970
Views on SlideShare
970
Embed Views
0

Actions

Likes
0
Downloads
3
Comments
0

0 Embeds 0

No embeds

Accessibility

Categories

Upload Details

Uploaded via as Microsoft Word

Usage Rights

© All Rights Reserved

Report content

Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
  • Full Name Full Name Comment goes here.
    Are you sure you want to
    Your message goes here
    Processing…
Post Comment
Edit your comment

Excellence in research Excellence in research Document Transcript

  • Vice Chancellor: Professor R F Boucher, CBE, PhD (Nottingham), HonDHL (State University of New York), CEng, FIMechE, FASME, MIEEE, HonRNCM, FREng SCHOOL OF MEDICINE & BIOMEDICAL SCIENCES Dean of School: Professor A P Weetman, MB BS, BMedSci, MD, DSc(Newcastle Upon Tyne), FRCP (London & Edinburgh), FMedSci DIVISION OF GENOMIC MEDICINE Director of Division: Professor G W Duff, MA, BM, BCh(Oxford), PhD(London), FRCP(Edinburgh & London), FMedSci SECTION OF ONCOLOGY AND PATHOLOGY Head of Section: Professor C E Lewis, BSc(Reading), DPhil(Oxford) ACADEMIC UNIT OF CLINICAL ONCOLOGY Head of Unit: Professor R E Coleman, MB BS, MD(London), FRCP(London & Edinburgh) SENIOR CLINICAL LECTURER IN MEDICAL ONCOLOGY REF NO: R3805 Applications are invited for the full time post of Senior Clinical Lecturer in Medical Oncology within the Academic Unit of Clinical Oncology, Division of Genomic Medicine, tenable immediately. Applicants should have their Certificate of Completion of Specialist Training (CCST) in medical oncology or be within three months of the CCST date and have an established track record in clinical research The postholder will be responsible to Professor B W Hancock but will work closely with Professor R E Coleman, Professor of Medical Oncology and Head of the Academic Unit. S/he will have a major role in developing clinical research in the field of late effects of cancer. The post will be based at Weston Park Hospital with clinical commitments at the Jessop Wing and with strong links with scientific colleagues in the Medical School. The appropriate Honorary Clinical Contract will be requested from the Sheffield Teaching Hospitals NHS Foundation Trust. THE UNIVERSITY OF SHEFFIELD - INFORMATION FOR APPLICANTS The University of Sheffield, which celebrates its centenary in 2005, is one of the UK’s leading universities, with an international reputation for excellence in both teaching and research. 1
  • Excellence in research In constantly developing the quality and diversity of its research across a wide range of subjects, the University has appointed many outstanding academics to its multidisciplinary research groups. In the most recent national Research Assessment Exercise, 35 subject areas achieved the top two grades, 5* and 5 – only five other universities exceeded that number. Our annual income for pure and applied research is fast approaching £100 million. Sheffield University Enterprises Ltd (SUEL), a wholly owned technology transfer subsidiary, has a portfolio of more than 70 projects developed out of University of Sheffield research, and more than 40 companies have already been founded. For example, one of these spin-out companies, CellTran Ltd, recently launched its pioneering biological bandage, Myskin, for treating patients suffering from severe burns. Excellence in learning and teaching The University maintains high standards in its undergraduate programmes. In the national Quality Assurance Agency’s Subject Reviews, the University has earned ‘excellent’ ratings in 29 subjects – the third highest number among all UK universities. The QAA’s institutional audit report on the University places it in the best of the three categories – “broad confidence” – in both the management of the quality of its academic programmes and the academic standards of its awards. Strategic alliances The University of Sheffield is a founder member of two major alliances. The Worldwide Universities Network is a consortium of 16 research-led universities in the UK, mainland Europe, USA and China. It exists to capitalise on growing global markets in research, postgraduate degree programmes and continuing professional development. The White Rose Consortium of Leeds, Sheffield and York universities exploits the combined research power of the three institutions and invests in spin-out companies. International and national honours In the 1990s two of our graduates won Nobel Prizes – Dr Richard Roberts for Medicine/Physiology in 1993 and Professor Sir Harry Kroto for Chemistry in 1996. Three other Nobel Laureates are associated with the University: Lord Florey (Medicine/Physiology, 1945), Professor Sir Hans Krebs (Medicine/Physiology, 1953) and Lord Porter (Chemistry, 1967). Since 1998 three Queen’s Anniversary Prizes, academic equivalents to the Queen’s Award for Enterprise, have recognised the University’s pioneering work – in creating definitive electronic editions of major literary texts, in environmental consultancy for industry and government, and in research into improving the health and social care of older people. Campus, students and staff The University received its Royal Charter in 1905, although its roots go back to 1828, when the Sheffield School of Medicine was founded. The academic buildings – a mixture of Edwardian and modern – are set in pleasant suburbs in the west of Sheffield, close to the Peak District National Park yet within easy reach of the city centre. A five-year £100 million building programme is providing new and refurbished accommodation for many departments, as well as state-of-the-art sports facilities. We are investing £16 million in a new learning 2
  • resources centre to provide an advanced integrated learning environment for our students. There are 25,000 full-time and part-time students studying in the University, of whom 19,450 are undergraduates and 5,550 postgraduates. Included in this figure are more than 3,846 international students from 116 countries. Working for the University The University has an ambitious HR strategy and recognises that its success depends upon recruiting, rewarding and developing high-quality staff in all areas. We are Sheffield’s third largest employer, with 6,000 staff working in a wide range of jobs, and we are proud to recognise that our success is due to the personal contribution made by all our staff. Working at the University will offer you exciting and rewarding opportunities within a dynamic and diverse workplace. The City of Sheffield Sheffield offers outstanding quality of life, an attractive, green environment, affordable living costs, excellent schools, short travel-to-work times, leading NHS care and a wide choice of housing. According to the latest Home Office crime statistics, Sheffield is England’s safest city. A recent Barclay’s survey revealed that Sheffield Hallam, the parliamentary constituency which includes much of our campus, is the second most affluent in England in real terms. As you would expect in England’s fourth largest city, there is a wealth of leisure, entertainment, sports and recreational opportunities to suit all ages, tastes and abilities. What the neutrals say In the 2005 Times Good University Guide twenty of our departments hold top-ten positions in the subject league tables, which are based on teaching and research quality, entry qualifications and graduate destination data. In the Virgin 2005 Alternative Guide to British Universities, which focuses strongly on the quality of the student experience, the University of Sheffield is rated very highly: ”Sheffield is a top university across the board. Whichever one of our statistical boxes you care to consult – Where Sheffield Graduates End Up, Academic Excellence, What It’s Really Like – they excel.” Further information on the above areas is also available at www.sheffield.ac.uk/jobs and www.sheffield.ac.uk/about SCHOOL OF MEDICINE AND BIOMEDICAL SCIENCES The Medical School, although physically located at the Royal Hallamshire Hospital site, also has Divisions/Sections based in the other hospitals in the city, in particular at the Northern General Hospital, and also at three specialist hospitals – Sheffield Children’s Hospital, the Jessop Wing and Weston Park Cancer Hospital. Currently, the Medical School has 190 academic staff and an annual intake of 238 students to the MBChB course (UCAS A106). The School was graded at 5 in the last Research Assessment Exercise. The administrative structure within the Medical School brings together a wide range of disciplines, grouped into three Academic Divisions, each with an executive director. The infrastructure of the School of Medicine is currently 3
  • undergoing a major refurbishment (funded by the Wellcome Trust and the University of Sheffield) to provide up to date facilities for basic and clinical research centred on the Royal Hallamshire Hospital site. Biomedical Science is located in the Western Bank complex that houses the School of Biology, which also includes the Departments of Molecular Biology & Biotechnology and Animal and Plant Sciences. The total staff in the Department is currently in excess of 150 including about 35 academic staff together with technicians, postdoctoral research fellows and postgraduate students. The curriculum of the MBChB course integrates clinical medicine and medical sciences throughout all years. Both academic staff and NHS clinicians teach and assess students. Such staff also provide opportunities for students to undertake intercalated Bachelor of Medical Sciences courses and offer briefer research attachments lasting a few weeks. DIVISION OF CLINICAL SCIENCES (SOUTH) The Division encompasses a broad range of disciplines with strong research activities in both basic science and clinical areas. Throughout the Academic Units, our goal is to apply basic science in clinical research. The Division is responsible for providing a substantial clinical service together with the teaching of undergraduate and postgraduate students. The total staff in the Division is in excess of 250 which includes a mix of academic, clinical academic, postdoctoral fellows, secretarial and technical support. In addition, we have over 50 registered PhD students and 40 MD students, together with masters and undergraduate students on taught courses. The Division has strong research groups, of both national and international standing, in both basic and clinical areas. Academic Units include Anaesthesia, Child Health, Clinical Pharmacology, Ophthalmology and Orthoptics, Palliative Medicine, Radiology, Reproductive Medicine, Sports Medicine, Surgical Oncology and Urology. Research in the Division is funded by the MRC, NCRI, Wellcome Trust, Department of Health, YCR, CRUK and other funders through programme and project grants. DIVISION OF CLINICAL SCIENCES (NORTH) The Division of Clinical Sciences (North) is based at the Northern General Hospital and is due to be relocated at the Royal Hallamshire Hospital site in April 2006. It incorporates the Sections of Cardiovascular Science and Human Metabolism. Academic Units include: cardiovascular, immunobiology, vascular, bone metabolism, human nutrition, nephrology, skin research and diabetes & endocrinology. A wide variety of funding for basic science and clinical research has been secured in the form of programme grants, project grants, studentships and fellowships from the Arthritis Research Campaign, BBSRC, BDA, British Heart Foundation, FSA, Heart Research UK, NKRF, Medical Research Council, SAKA, SKRF, Wellcome Trust as well as funding from a number of commercial companies. The total number of staff and students in the Division is in excess of 180 which includes academic, clinical academic, postdoctoral research fellows, research assistants/associates, technical and secretarial staff. There are over 100 postgraduate students registered for PhD/MPhil and MD courses in addition to undergraduate and masters students. 4
  • DIVISION OF GENOMIC MEDICINE The Division comprises three sections of Genetics and Informatics, Functional Genomics and Oncology and Pathology including Forensic Pathology. The Division was formed from the amalgamation of Molecular and Genetic Medicine, Cancer Studies, Human Metabolism and Clinical Biochemistry, Pathology, Forensic Pathology and Clinical Oncology. The Division of Genomic Medicine provides clinical services in: Medical Oncology; Haematology; Respiratory Medicine; Rheumatology; Infectious Diseases; Dermatology; Neurology; Psychiatry; Pathology (including Forensic Pathology and Neuropathology) and Microbiology. There are strong research programmes in fundamental and clinical aspects of these branches of Medicine, including MRC Co-op, Wellcome Trust, ARC, YCR and industrial supported groups. The Division comprises of 400 members of staff and postgraduate students. RESEARCH IN THE SCHOOL OF MEDICINE & BIOMEDICAL SCIENCES This is currently grouped into six research themes. Cancer Research Theme Cancer research in Sheffield has well-established programs in both basic and clinical research. The basic research program is based in the Institute for Cancer Studies, which occupies 800 sq. metres of newly refurbished space on the top floor of the Medical School. As well as research space for seven investigators, the Institute provides core facilities for cancer researchers throughout Sheffield. These facilities include fluorescent activated cell sorting (FACS), DNA sequencing, high throughput DNA sample processing, confocal and time-lapse microscopy, and a radiation source. The Academic Unit of Clinical Oncology is located in the Cancer Research Centre (CRC), a purpose built clinical trials facility at the Weston Park Hospital. The CRC provides facilities for the assessment and treatment of patients, office space for staff with fully networked computer systems, and specialist facilities including laboratory space and bone densitometry. The North Trent Cancer Research Network (NTCRN) is co-ordinated from the CRC. Cardiovascular Research Theme The theme comprises strong groups working in basic and clinical science. These groups are the Cardiovascular Research Group, the Academic Unit of Haematology, the Academic Unit of Anaesthesia, the Academic Unit of Clinical Pharmacology and the Academic Unit of Medical Physics and Clinical Engineering (cardiovascular group). The theme covers genetic, cellular and clinical research in cardiovascular medicine. Main areas are coronary artery disease, cardiovascular pharmacology, the microcirculation, haemostasis and thrombosis, and cardiovascular modelling. This group currently has programme grant funding from the British Heart Foundation (BHF), a number of project grants as well as an MRC Establishment Grant, Clinical Training Fellowships from the MRC and Wellcome Trust funding. The Haemostasis and Thrombosis group at the Royal Hallamshire Hospital has established international status including co-ordinator status for EU FP5 project funding, and additional funding from Wellcome and BHF. The group within Medical Physics has similar European and international collaborations with significant associated grant funding (CEC, FP5, EPSRC). 5
  • Endocrinology and Reproduction Research Theme The strength of the Endocrinology and Reproduction research theme is in translational research; from the laboratory to the patient and from clinical research to service delivery. Hormones regulate both single cell and whole body metabolism and the study of hormones and cell biology underpins the Endocrinology and Reproduction research theme. Stem cells provide great promise and the Jessop Wing with its integrated assisted conception unit and HFEA approved research laboratories provides the ideal infrastructure for collecting, developing and applying stem cell technology. The innovative nature of Endocrinology Research theme basic research is illustrated by the successful formation of two spinout companies one developing stem cells, Axordia Ltd, and the other cytokine receptor modulators, Asterion Ltd. Diabetes and thyroid disease are the commonest endocrine conditions each affecting up to 5% of the population. The identification of antigens in autoimmune endocrine disorders is a major focus of the Endocrinology and Reproduction research theme. The University of Sheffield Diabetes group has been instrumental in changing UK clinical practice with the introduction of new methods for empowering patients, the DAFNE project, and investigating the commonest complication of diabetes, hypoglycaemia in both Type 1 and Type 2 diabetes. The Endocrinology and Reproduction research theme has particular strengths in Clinical Research with the UK’s largest integrated endocrine unit allowing the development of specialised clinics with a particular emphasis on pituitary disease and transitional care of paediatric patients. The groups in the Endocrinology and Reproduction theme include: Diabetes, Endocrine Autoimmunity, Neuroendocrinology, Paediatric Endocrinology, Reproduction and are located in Clinical Sciences (North), The Jessop Wing, and The Children’s Hospital. Infection, Inflammation and Immunity Research Theme The 3Is research theme incorporates basic science groups working in molecular cell biology with clinical specialities including respiratory medicine, infectious diseases, rheumatology and dermatology. This grouping received a 5* rating from the 2001 RAE Infection and Immunity sub-panel. There is a substantial base of Wellcome Trust funding, together with MRC and BHF support. There are 2 clinician scientists (1 Wellcome Trust, 1 MRC) and an MRC Co-operative Group “Mechanisms of Cytokine Action in Chronic Inflammation.” Although the majority of theme members are within the Division of Genomic Medicine, there are important contributions from Biomedical Sciences, Endocrinology and others. Musculoskeletal Research Theme The Musculoskeletal research theme comprises groups working in both basic and clinical science. These groups include the Bone Metabolism Group, the Bone Biology Group, the Childrens Bone Disease Group and the Academic Rheumatology Group. Research activity within the theme includes genetic, cellular, molecular and clinical research into common musculoskeletal disorders. The main areas of research are in the metabolic bone diseases, such as osteoporosis, childhood bone disease including osteogenesis imperfecta, in the bone oncology area, particularly in tumour induced bone diseases such as multiple myeloma, and metastatic bone disease, and in the rheumatic diseases. There is substantial cross theme cooperation, for example collaboration with members of Cancer theme in the bone oncology area is a major strength. Research activity within the Musculoskeletal research theme is supported through a broad portfolio of research funding. This includes project and programme grant support from major U.K. funding organizations such as the Medical Research Council, the Arthritis Research Council, and the Leukaemia Research Fund. Substantial support from biotechnology and pharmaceutical companies has formed 6
  • the basis for significant translational and clinical research programmes. A major emphasis of the Musculoskeletal theme is in career development. This has been demonstrated by the success of members of the theme in attaining personal support through Fellowship schemes, which include Arthritis Research Council Clinician Scientist and Clinical Research Fellowship awards. Neurosciences Research Theme Clinical Neurosciences research in Sheffield has been strengthened by recent strategic investments in Neurology, Neuropathology and Biological Psychiatry. This development is based on common research interests in neurodegenerative diseases (diseases of the motor system, basal ganglia and dementia) and neuropsychiatric disorders (psychosis and major affective disorders). We are strategically placed to combine interdisciplinary methodologies from animal and cell models, access to populations across South Yorkshire in human genetic, structural and functional neuroimaging studies, and to develop and investigate novel pharmacological, surgical and psychological interventions. There are 3 main research groupings: Neurology/Neuropathology; Biological Psychiatry; and Neuroimaging. There are other areas of strong Neuroscience research within the University of Sheffield. These include Cellular and Molecular Neuroscience groupings within the two main component institutes of Biological Sciences (Institute of Molecular Physiology and Centre for Development Genetics) whose main strengths are in developmental neuroscience, and the role of P2X receptors and extracellular signalling by ATP, and sensory signal transduction. There are also strong groupings in Cognitive Neuroscience in the department of Psychology including: structure and function of the basal ganglia and related circuits; drug dependence; reparative strategies in retinal degeneration; functional imaging; psychopharmacology, Medical Physics, Human Communication Sciences. SHEFFIELD TEACHING HOSPITALS NHS FOUNDATION TRUST Sheffield Teaching Hospitals became one of the first NHS Foundation Trusts on July 1st 2004, and manages five major hospitals in Sheffield – the Northern General, Royal Hallamshire, Jessop Wing, Weston Park and Charles Clifford Hospitals, making it the second largest NHS Trust in England. As a Trust, Sheffield Teaching Hospitals is responsible for the planning and delivery of the highest quality patient care, providing services for patients not only from Sheffield but all parts of the UK. The annual budget is approaching £520 million, with almost one million patients each year. Further details are included in the attached document ‘Profile of Sheffield Teaching Hospitals NHS Foundation Trust’. SECTION OF ONCOLOGY AND PATHOLOGY The Section of Oncology and Pathology comprises three sub Sections - Clinical Oncology, Cancer Studies and Pathology. It seeks to integrate and lead cancer research across Sheffield and North Trent whilst maintaining the existing high standard of undergraduate and postgraduate teaching. Since the appointment of Professor Mark Meuth as Head of the Institute for Cancer Studies there has been emphasis on the molecular genetics of cancer. This is an accord with the University of Sheffield major initiative in Molecular Genetics where there is cross-University collaboration particularly with the Division of Genomic Medicine and Department of Molecular Biology & Biotechnology. On the clinical front the Cancer Research Centre (a joint venture between Charitable Appeal, Weston Park Hospital, University of Sheffield and Industry) to enhance collaborative clinical trials and bone metastasis 7
  • research opened in 1999. In Pathology senior appointments have strengthened clinical molecular pathology research. ACADEMIC UNIT OF CLINICAL ONCOLOGY Academic staffing of Clinical Oncology is as follows: Professor B. W. Hancock, Deputy Director (Clinical) of Division of Genomic Medicine Professor R. E. Coleman, Professor of Medical Oncology Professor P. J. Woll, Professor of Medical Oncology This post, Senior Clinical Lecturer, Medical Oncology Dr M. H. Robinson, Reader, Clinical Oncology Dr J. E. Brown, Lecturer, Medical Oncology Dr J. Lester – Clinical Lecturer, Clinical Oncology In addition there is a full complement of research nurses, research assistants, secretarial and technical staff and clinical research fellows. Clinical Oncology Research Interests: Bone oncology; evaluation of new anticancer agents; multi-disciplinary treatment of lymphoma; high dose and dose intensive chemotherapy; technical developments in radiotherapy; gestational trophoblastic disease; supportive care in oncology; lung cancer biology Staff: Professor R. E. Coleman, Professor B. W. Hancock, Dr M. H. Robinson, Professor P. J. Woll, this post Cancer Studies Research Interests: Genomic instability in cancer cells; cytokines and cell signalling; apoptosis and cell cycle control; cyto- and molecular genetic changes; cellular immunology and immuno-therapy Staff: Dr A. Cox, Dr T. Helleday, Professor M. Meuth, Dr C. M. Sanders Pathology Research Interests: Molecular pathology; tumour angiogenesis; gene therapy; diagnostic decisions support systems; health service pathology research Staff: Dr M. Barker, Dr J. Burton, Dr S. S. Cross, Professor P. G. Ince, Professor C. E. Lewis, Professor J. C. E. Underwood, Professor M. Wells, Dr S. B. Wharton THE NORTH TRENT CANCER RESEARCH NETWORK (NTCRN) The NTCRN is based at the Cancer Research Centre at Weston Park Hospital (WPH) within the Sheffield Cancer Centre. The Network extends across Sheffield and to the Cancer Units at Barnsley, Chesterfield, Doncaster/Bassetlaw and Rotherham. The catchment population is 1.7 million. Cancer services in North Trent are well organised along the lines envisaged in the Calman-Hine report with multi-disciplinary teams across all tumour types. Clinical research is recognised as an important component of standard care within these teams. Comprehensive research infrastructure is now provided through a 8
  • combination of National Health Service Research and Development (NHS R&D) funds and National Cancer Research Network (NCRN) monies. Clinical trial participation exceeds 10% into NCRN approved trials and overall trial participation is close to 15%. A research nurse to facilitate recruitment and management of patients in clinical trials supports all of the major multi-disciplinary teams. WESTON PARK HOSPITAL Weston Park Hospital is the base for the Oncological Service for South Yorkshire, North Nottinghamshire and North Derbyshire. It is one of the major Radiotherapy Units in the country and is sited in the main hospital area of the city within a quarter of a mile from the University, the Children’s Hospital, the Jessop Wing and the Royal Hallamshire Hospital. There are approximately 3,500 admissions and over 6,000 new patients registered annually. It is a self-contained unit with 101 beds, 28 of which are dedicated to the treatment of chemotherapy daycases. Weston Park Hospital acts as an NSCAG supra-regional referral centre for the diagnosis and treatment of gestational trophoblastic disease and a national and European centre for the treatment of arterio-venous malformations with the stereotactic radiosurgery unit (in conjunction with the neurosurgeon). There is a chemotherapy suite and daycase services unit and between them they offer the opportunity to treat 28 patients at any one time. There are outpatient facilities, a radiotherapy department (see below), theatre facilities and pharmacy with a reconstitution service for cytotoxic chemotherapy. A Teenage Cancer Trust Unit for adolescents, jointly funded between the Teenage Cancer Trust and Weston Park Hospital Cancer Appeal, was completed in 2002. Approval has recently been obtained for a major re-development on site which by 2004/05 will result in increased linacc, outpatient, day case and day ward facilities. There is an Academic Unit of Clinical Oncology, with representatives in medical oncology, radiation oncology and, most recently, surgical oncology, the latter in association with the Department of Surgery at the Royal Hallamshire Hospital. (i) Radiology There is a diagnostic imaging department with x-ray ultrasound apparatus and impression suite facilities are provided in close association with the simulator suite and the radiotherapy department. Diagnostic isotope and CT scanning is on site and MRI scanning facilities are available at the Royal Hallamshire Hospital. In addition to radiotherapy there are facilities for surgery and an expanding programme of cytotoxic chemotherapy. The hospital also houses a large radiotherapy and physics department and provides an ocular oncology service in conjunction with the ophthalmic surgeons at the Royal Hallamshire Hospital, who have achieved NSCAG status. (ii) Radiotherapy The radiotherapy equipment is housed in a large treatment hall and comprises:  Seven Varian Linear Accelerators, comprising:- 9
  • Four Clinac 6 MV Accelerators – two with MLCs Three dual energy (6 MV and 10 MV) Accelerators with electron facilities and MLCs Five of seven are new machines, provided by NOF programme with capability of delivering IMRT  One spare bunker  One 250 kV Orthovoltage Machine  One Pantak Superficial Set  One Varian Simulator  One Lexsell Stereotactic Radiosurgery Unit  LDR Selectron for gynaecological use in a purpose built extension  Two Virtual Simulator (spiral CT scanner with specific planning software). One has wide bore aperture There are facilities for the use of unsealed isotopes in therapy and diagnosis. (iii) Pathological Services Haematology and histopathology services are currently provided from the Royal Hallamshire Hospital. A service for chemical pathology, bacteriological and other specialised investigations is provided by the appropriate departments in nearby hospitals. Phlebotomists are employed at Weston Park Hospital for both inpatients and outpatients. (iv) Outpatient Services There are outpatient facilities within the hospital with 4 consulting suites and approximately 58% of our outpatient work is carried out at Weston Park Hospital. However, the remaining 42% are seen as outpatients in the local district general hospitals. There is an outpatient chemotherapy suite staffed by appropriately trained nurses. (v) Research and North Trent Cancer Service There are excellent opportunities for clinical research, co-ordinated by the Clinical Trials Centre at Weston Park Hospital. The Clinical Trials Centre is a phase I National Cancer Research Network site. Support for health services research is provided by Sheffield University’s School for Health Related Research (ScHARR). The “North Trent Cancer Network”, which co-ordinates cancer services across all Trusts in North Trent covering a population of nearly 2 million, provides overall co-ordination of cancer developments, clinical cancer research and audit. There has been considerable emphasis on the need for joint consultation in the treatment of malignant disease and joint clinic sessions are held with Consultants in other specialities including haematology, surgery, endocrinology, dermatology, gynaecology, urology, paediatrics, ENT and maxillofacial surgery. MANAGEMENT ARRANGEMENTS Clinical Directorates became operational at the Royal Hallamshire Hospital on 1 April 1991 and are now well established. Clinical Directors are appointed by the Chief Executive for a three year period, subject to annual review. 10
  • Clinical Director, Oncology – Dr M H Robinson Lead Clinician for Chemotherapy Services – Dr L S Evans Clinical Director, Radiation Services – Dr P Kirkbride Lead Clinician for Radiation Services – Dr S D Pledge Senior Manager, Radiation Services – Mrs M Tomlinson General Manager – Mrs P L Mackender Nurse Director – Mrs A Pulfrey Business Manager – Mrs G Marsden Senior Group Accountant – Mr R Panek STAFFING (a) NHS Consultants in Clinical Oncology Special Interest Dr K S Dunn Breast cancer Dr P M Fisher Lung and oesophageal cancer Dr C Ferguson Urological oncology Dr M Q Hatton Lung/breast cancer Dr P Kirkbride Urological oncology/lung cancer Clinical Director Radiation Services Dr D P Levy CNS tumours Dr I H Manifold Breast/thyroid cancer Dr J Mohanamurali Gynae/lung Dr B Foran Breast/lung/head & neck cancer Dr D Furniss GI Malignancies/melanoma Dr S D Pledge Gynaecological oncology/paediatric radiotherapy Dr O P Purohit ENT/maxillofacial/breast cancer Dr D J Radstone Gynaecological/colorectal cancer Dr S Ramakrishnan Breast cancer Dr J Wadsley Lung/GI/thyroid (b) NHS Consultants in Medical Oncology Special Interest Dr L Evans Upper GI/lymphoma/high dose chemotherapy Dr J Hornbuckle Ovarian/GI (c) Consultants in the Academic Unit of Clinical Oncology The Academic Unit of Clinical Oncology was established as a joint initiative between the University, the Yorkshire Cancer Research Campaign and (former) Trent Regional Health Authority. The clinical base is situated at Weston Park Hospital. Laboratory facilities are based at the adjacent Royal Hallamshire Hospital within the Institute of Cancer Studies. There is a complete integration of the department within the National Health Service and research facilities are available, if required, to the appointee. 11
  • Special interest Professor B W Hancock Lymphoma Professor of Clinical Oncology Biological therapy (Honorary NHS Consultant) Choriocarcinoma Professor R E Coleman Breast cancer Professor in Medical Oncology Metastatic bone disease (Honorary NHS Consultant) Professor P Woll Lung cancer Professor in Medical Oncology Sarcomas (Honorary NHS Consultant) Dr M H Robinson Sarcomas Clinical Director ENT Reader in Clinical Oncology Maxillofacial (Honorary NHS Consultant) Lymphomas Senior Clinical Lecturer in Medical Gynae, biological therapy, Oncology (This post) melanoma, renal cancer (Honorary NHS Consultant) (d) Junior Medical Staff Clinical Lecturer in Clinical Oncology (with Honorary Specialist Registrar status) Clinical Lecturer in Medical Oncology (with Honorary Specialist Registrar status) Eleven Specialist Registrars in Clinical Oncology Six Specialist Registrars in Medical Oncology Four Specialist Registrars in Palliative Medicine (rotation through WPH) Three Clinical Research Fellows Five Senior House Officers Two Trust Grades One Senior House Officer (VTS for general practice) – half time Weston Park Hospital, half time St Luke’s One Senior House Officer responsible for the care of patients with gestational trophoblastic disease One pre-registration House Officer rotating between oncology (Professor Hancock) and general medicine, Royal Hallamshire Hospital (e) Other Medical Staff Two Consultant Radiologists (sessional attachment) Two Consultant Anaesthetists (sessional attachment) Two Staff Grade Doctors Three GP Clinical Assistants (f) Support Staff (including nursing, professional and technical staff) There is a full establishment of nursing staff, radiographers, physicists and physics technicians (including an impression suite). Current trainee staffing will be shared with the new Consultant. 12
  • THE CANCER RESEARCH CENTRE The Cancer Research Centre based at Weston Park Hospital is a purpose built Unit. Patients from across North Trent will have access via entry into clinical trials to new and innovative treatments in the field of cancer care. A large number of clinical trials are in progress in the clinical management of, and research in, breast cancer, soft tissue sarcomas, lymphoma, ovarian cancer, bone metastases, biological therapy of malignant melanoma, renal cell carcinoma, colorectal carcinoma, lung cancer, teratoma and supportive care. Priorities for the NTCRN are lung, breast colorectal, lymphoma, leukaemia and prostate cancers. A bone densitometer has been installed to enable detailed assessment of skeletal changes in patients with and without metastatic bone disease. Both the academic and NHS departments at Weston Park Hospital have an active commitment to national and international multicentre trials with a high profile in British National Lymphoma Investigation (BNLI), Medical Research Council (MRC) and European Organisation for Research and Treatment of Cancer (EORTC) studies. SENIOR CLINICAL LECTURER IN MEDICAL ONCOLOGY The role of non-surgical oncology in melanoma is increasing, particularly within the context of clinical trials. The establishment of the North Trent Network provides the clinical impetus and population resources for such clinical studies. There is also increasing interest in the molecular genetic basis of cancer – the Sheffield Institute for Cancer Studies has laboratory and personal resources to facilitate collaborative (translational) research. The candidate should, therefore, have an established track record in clinical research, preferably in the field of late effects of cancer. S/he will be expected to establish collaborative clinical and translational research in this field working with clinical and scientific colleagues (particularly Professor R E Coleman at Weston Park Hospital). Office accommodation and secretarial support will be available at Weston Park Hospital. The postholder’s NHS commitments (PAs) will be at Weston Park Hospital (3.75 DCC, 1.25 SPAs). S/he would be encouraged to participate in CME activities. This is a full time, permanent post (10 PAs – 5 NHS, 5 University) – Band 2, on call commitment category B, 2%. Applicants should have MRCP and full GMC Registration. Duties of post: Research The successful applicant will be expected to be involved in the areas of research in the Academic Unit of Clinical Oncology. Teaching The postholder will contribute to the undergraduate and postgraduate teaching programmes of the School and will also be involved with the assessment of students and have personal mentoring responsibilities for a small group of students on the MBChB programme. 13
  • Clinical The postholder will be responsible for: 1. the management of ovarian cancer patients discussed at the Sheffield gynae MDT 2. the systemic treatment of malignant melanoma Specimen timetable Monday Tuesday Wednesday Thursday Friday am Gynae Clinic, Melanoma Ward Round Jessop Wing Research (1 hr DCC) (3 hrs 30 Clinic/Ovarian DCC) Research Clinic (1 hr 30 DCC) Lunch pm Ward Round Admin (3 hrs Melanoma (1 hr DCC) DCC) Clinic, WPH Gynae MDT, (3 hrs DCC) Jessop Wing (2 hrs DCC) Total 6 hrs 30 4 hrs 30 4 hrs (1 DCC) (1.625 DCC) (1.125 DCC) Administration The postholder will be required to undertake administrative work in support of the needs of the Academic Unit of Clinical Oncology and the University of Sheffield. Administrative duties will be determined with the Head of Unit but should not detract from the research needs of the postholder. PERSON SPECIFICATION ESSENTIAL DESIRABLE QUALIFICATIONS MRCP or equivalent Full GMC Registration Higher research degree EXPERIENCE CCST medical oncology Specialist experience TEACHING Previous undergraduate Evidence of innovation in and postgraduate teaching teaching experience RESEARCH Track record in previous Evidence of standing in the medical oncology research, profession through invited with evidence of publication lectures, membership of in this field national or international bodies etc. Substantial research activity with evidence of research grant income MANAGEMENT Ability to lead a research Previous NHS or project team management experience INTER-PERSONAL The post requires working Experience of managing SKILLS in a multi disciplinary team, others in the clinical and as such and high level environment. 14
  • of communication capability is required FURTHER INFORMATION FURTHER INFORMATION: Please note that as this post is exempt from the Rehabilitation of Offenders Act 1974, a satisfactory Criminal Records Bureau Disclosure will be required for the appointee. If you have a spent criminal record and are invited to interview for this type of post, you are requested to provide details of your convictions, with the post reference, in advance of the interview to the Head of the Staff Recruitment Service, Department of Human Resources, University of Sheffield, Sheffield, S10 2TN (mark the envelope PERSONAL). This information will be treated as strictly confidential and will only be considered if you are invited to interview for the post. The appointee will also be required to complete a medical health assessment questionnaire with the Sheffield University Occupational Health Department. The appropriate Honorary Clinical Contract will be requested from the Sheffield Teaching Hospitals NHS Foundation Trust. INFORMAL ENQUIRIES: Informal enquiries/visits are welcome and potential candidates should contact: Professor B W Hancock Dr M H Robinson Professor of Clinical Oncology Clinical Director/Reader in Clinical Oncology Tel: 0114 226 5207 Tel: 0114 226 5212 B.W.Hancock@sheffield.ac.uk M.H.Robinson@sheffield.ac.uk Potential candidates, particularly if currently working overseas, are welcome to establish contact by email and should not regard a visit to Sheffield before short listing as a prerequisite to consideration. The University of Sheffield website (http://www.sheffield.ac.uk/) provides useful information about the university and city. SALARY: Salary will be based on your seniority at point of transfer to the new Consultant Contract, plus your progression after this point. Please refer to payscales on appendix 1. The postholder will participate in an out of hours working pattern with NHS colleagues which is currently assessed at pay band B. TERMS AND CONDITIONS OF EMPLOYMENT: As for Senior Clinical Lecturers, attached. Please note that the terms and conditions for all appointments are currently being reviewed as part of the implementation of the University of Sheffield Grading Scheme. New appointees will be provided with the final version on appointment. BENEFITS FOR STAFF In addition to competitive pay and generous holiday entitlements, our staff enjoy access to: 15
  • • final salary pension scheme • corporate Childcare Vouchers scheme • Home Computing Initiative scheme: www.sheffield.ac.uk/hci • special staff rates for S10 Health membership: www.sheffield.ac.uk/s10/index.html • outstanding sports and recreational facilities. CLOSING DATE: 3 January 2006. PLEASE QUOTE REFERENCE NO: R3805 HOW TO APPLY: Online: Please visit www.sheffield.ac.uk/jobs, click on the title of the post you wish to apply for and select the 'apply online' link. Or please send: a) your full curriculum vitae with a covering letter explaining your interest in, and suitability for, this vacancy (two copies of each) b) a completed Summary Information Form/Equal Opportunities Monitoring Form by post to: The Staff Recruitment Service Department of Human Resources The University of Sheffield Firth Court Western Bank SHEFFIELD S10 2TN or in person to: The Staff Recruitment Service Department of Human Resources The University of Sheffield 10 - 12 Brunswick Street SHEFFIELD S10 2FN (Reception is open Monday-Friday 9am - 5pm). CIRCULATION OF APPLICATIONS As part of the selection process, applications may be considered by a number of appropriate staff within the recruiting department, and a cognate department, in addition to the shortlisting/interview panel(s). Please state within your covering letter if you do not wish your application to be released in this manner, or whether you would prefer it to be circulated on a restricted basis, e.g. as an anonymous CV. INTERVIEW EXPENSES Candidates attending for interview will be provided with the appropriate claim form. The University will defray standard return rail fare and reasonable subsistence expenses. Claims for car mileage are accepted when it is agreed in advance that rail travel is not a practicable alternative. Arrangement for travel from outside the UK must be made with the recruiting department in advance of the interview. To meet Inland Revenue requirements, expense claims must be accompanied by original receipts. 16
  • WORK PERMITS If an applicant selected to be appointed requires a work permit to work in the UK, the University may issue a conditional offer of employment subject to a successful work permit application. The Home Office is the Government department charged with the responsibility of issuing work permits. It has in place strict criteria regarding eligibility and work permits will only be issued for posts where it can be demonstrated that there is a skills shortage which cannot be met from within the European Economic Area. Where it is reasonable to assume that there is an appropriate recruitment market within the EEA, it is unlikely that a work permit will be issued. Therefore certain types of post are unlikely to be considered eligible for a work permit. Further information is available on the Home Office website at: http://www.workingintheuk.gov.uk/. The persons whom the University considers may not be limited to those who make applications in accordance with the current advertisement. The University is committed to equality through diversity 17
  • Profile of Sheffield Teaching Hospitals NHS Foundation Trust Sheffield Teaching Hospitals NHS Foundation Trust manages five major hospitals in Sheffield - the Northern General, Royal Hallamshire, Jessop Wing, Weston Park and Charles Clifford Hospitals. As a Trust, we are responsible for the planning and delivery of the highest quality patient care, providing services for patients not only from Sheffield but all parts of the UK. We have an annual budget approaching £520 million and treat almost one million patients each year, making us the second largest NHS Trust in England. We became one of the first NHS Foundation Trusts in the country on July 1 st 2004. NHS Foundation Trusts have greater freedom from central government control and the ability to work with their community and staff to set local health priorities. Sheffield Teaching Hospitals was originally created through the merger of the Central Sheffield University Hospitals and Northern General Hospital NHS Trusts in April 2001. The Trust has achieved the highest rating of three stars in the annual NHS Star Ratings since its creation, which gave it the right to apply for foundation status. We are also proud of our record as having one of the lowest mortality rates in the country. The hospitals were one of just six trusts to be shortlisted for ‘Hospital of the Year’ in the annual UK Good Hospital Guide in 2004. Our Hospitals Although the Trust has overall management responsibility for the services provided, our hospitals each have their own history, which we are rightly proud of. Between them they offer just about every kind of service available in the modern NHS with over 12,000 members of staff working within them. The Northern General is the largest of our hospitals with 1100 beds. Located to the north of the city, the hospital is spread out over a large site. Amongst its specialist services are orthopaedics, spinal injuries and heart and lung services. Sheffield’s accident & emergency department is also based here. The other Trust hospitals are based closely together on a campus to the west of the city centre. The Royal Hallamshire is a major acute teaching hospital based around a ‘tower block’ of 760 beds and a large outpatient department. Specialist services here include neurology, urology and ophthalmology. Linked to the Royal Hallamshire by a footbridge, the Jessop Wing is Sheffield’s 260 bed women’s hospital. Opened in February 2001 it has brought together all of the city’s obstetric, gynaecology and neonatology services in a state-of-the-art, purpose built, £24 million building. Weston Park is one of only three purpose built specialist cancer hospitals in the UK and provides a full range of non-surgical cancer services to the population of South Yorkshire, North Nottinghamshire and North Derbyshire. It also enjoys national and international recognition for certain specific treatments. It has 112 beds and is home to a specialist cancer research centre. The Charles Clifford is a dental teaching hospital linked to the Sheffield University School of Clinical Dentistry. The hospital provides dental out-patient services and emergency dental services for the city. As a teaching Trust, all of the hospitals have close links to the University of Sheffield, home to Sheffield’s medical school, and Sheffield Hallam University. It is a major teaching centre for future health professionals. 18
  • Sheffield Teaching Hospitals NHS Foundation Trust Executive Team Chairman Mr David Stone OBE Chief Executive Mr Andrew Cash OBE Director of Human Resources Mr John Watts Director of Service Development Mr Chris Linacre Chief Nurse Mrs Heather Tierney-Moore OBE Director of Finance Mr Neil Priestley Medical Director Professor Chris Welsh Services Provided at Sheffield Teaching Hospitals NHS Foundation Trust Accident and Emergency Obstetrics/Gynaecology/ Neonatology Acute General and Elderly Medicine Occupational Health Service Anaesthetics Operating Services Cardiothoracic surgery & Cardiology Ophthalmology Chemotherapy Oral-maxillofacial Surgery Clinical Research and Development Orthopaedics Communicable Diseases Palliative medicine Critical Care Pharmacy Day Surgery Professions Allied to medicine Dental Services Radiology Dermatology Radiosurgery ENT, Hearing Services and Medical Radiotherapy Audiology General Surgery Reconstructive Plastic Surgery and Burns Haematology Reproductive Medicine Laboratory Medicine Renal Services Medical Physics Rheumatology Mobility and Specialised Rehabilitation Under and Post graduate Education Services Metabolic Bone Disease Urology Neuroscience Vascular Surgery 19
  • THE UNIVERSITY OF SHEFFIELD Vice-Chancellor: Professor R F Boucher, CBE, PhD (Nottingham), HonDHL(State University of New York), CEng, FIMechE, FASME, MIEEE, HonRNCM, FREng APPOINTMENT OF A SENIOR LECTURER (CLINICAL) TERMS & CONDITIONS OF SERVICE 1. (a) The post is full-time unless stated otherwise in your letter of appointment and may not be held in conjunction with any other engagement. (b) You are required to observe the Charter, Statutes and Ordinances of the University and to carry out all orders and regulations of the Council. (c) You are required to carry out such teaching, examining and administrative duties as may be assigned to you by your Head of Department, to whom you will be responsible, and to conduct research as an essential part of your duties. You are required to work such number of hours as are necessary to carry out your duties. 2. (a) The salary scales adopted by the University Council for staff in clinical grades are as set out in the attached document. (b) Initial salary will be fixed at a point within the salary scale depending on qualifications and experience. (c) Salary is payable monthly in arrear from the date of your taking up duties. (d) Increments are payable as follows: If your date of appointment is between 1 October and 31 March inclusive: first increment on the following 1 October with increments on each 1 October thereafter. If your date of appointment is between 1 April and 30 September inclusive: first increment on 1 October in the following calendar year with increments on each 1 October thereafter. In this case the initial salary will have taken into account the span of time prior to payment of the first increment. 3. You may, subject to the rules of the Universities Superannuation Scheme Ltd, become or continue as a member of the Universities Superannuation Scheme Ltd., or continue as a member of the National Health Service Pension scheme. A contracting-out certificate under the Social Security Pensions Act 1975 is in force for appointments subject to the Universities Superannuation Scheme and the National Health Service Pension Scheme. 4. You are required to reside within fifteen miles of the centre of the City of Sheffield unless you have obtained the permission of the Council of the University to live at a named place beyond that limit. 20
  • 5. Removal expenses will be paid in accordance with the regulations approved by the Council to staff taking up initial appointments with the University of not less than two years' duration and coming to live within that limit. 6. The National Health Service assumed financial responsibility from 1 January 1990 for negligent acts of their medical and dental staff in the course of their NHS employment. However various aspects of the work of some staff are not covered by the Crown Indemnity Scheme and clinical academic staff are therefore required as part of their terms and conditions of service to take out Professional Defence Organisation cover. 7. You are allowed annual holidays on full pay totalling six calendar weeks, exclusive of statutory bank holidays, in any one calendar year beginning on 1 October. Holidays shall be taken by agreement with your Head of Department. On termination of your employment, you will be entitled to take paid holiday or payment in lieu of holiday being the proportion of your entitlement for the period you have worked during the leave year and for which you have not taken holidays. Payment in lieu of holiday will not be made where agreement is made with a new employer to take over responsibility for accrued holiday entitlement. Holiday entitlement is not transferable from one leave year to another. 8. You will be a member of the Senior Common Room; membership carries with it the obligation (which is revocable) to payment of an annual subscription to be effected by deduction from salary in a single month of each year. 9. You are required to attend training and such courses on matters concerning Health, Safety and Welfare at Work as may be arranged for you. 10 It is the University's policy to encourage members of the academic staff to undertake a reasonable amount of consultancy work. In normal circumstances and subject to prior notification to your Head of Department, up to 35 days' paid outside consultancy may be undertaken in any academic year (taking term-time and vacations together); approval to undertake such consultancy shall not normally be withheld by Heads of Department provided the work involved is in the general interests of the University. Where a member of staff wishes to undertake a total of more than 35 days' consultancy in any one year, a recommendation must be made via the Head of Department to the Vice-Chancellor. If approval for more than 35 days is given, the fees received in excess of 35 days shall be the subject of individual negotiation but the share of the consultancy income accruing to the University and the Department shall not normally be less than 50% of the fee for the days beyond 35. 11 Appointments are terminable at any time by three months notice from either side, the notice taking effect (except in the case of non-teaching staff) at the end of a University Semester. However subject to mutual agreement the requirements for the notice to take effect at the end of a Semester may be waived. For staff who carry out teaching duties, full details of notice periods can be found on the Department of Human Resources web pages. 12. You are required by Statute to retire from your post on 29 September following the date on which you attain the age of 65 years unless the Council by a vote of 21
  • at least one-half its total members shall request you to continue for a period not exceeding five years after which retirement will be compulsory. 13. The Council has approved a formal procedure which you may follow if you wish to seek redress of any grievance relating to your employment. 14. The University Maternity Leave with pay scheme is available for female members of University staff who have been continuously employed in the University’s service for a minimum period of 12 months before the expected date of confinement. Copies of the University’s Maternity Leave Scheme are available in the Department of Human Resources. Other female members of staff may be eligible for Statutory Maternity Entitlements and they should contact the Department of Human Resources for advice concerning eligibility. Any male member of University staff who is the father of a new child is entitled to Paternity Leave. Paternity Leave Guidelines are available from the Department of Human Resources. 15. Paid leave of absence on grounds of ill health is granted in accordance with the regulations approved by the Council of the University. 16. If you believe that there is patentable property arising out of your University work you must inform the Registrar and Secretary as soon as possible and certainly before any disclosure or publication of the invention. The University will then determine as soon as possible whether it will proceed and file a patent application, agreeing with you that any future benefits of exploitation will be shared between you and your Department and the University, or will notify you that the University has no interest in the invention and that you are free to proceed at your own risk and cost. 17. No member of the University apart from the Registrar and Secretary as Secretary to the University Council or the Director of Human Resource Management has authority to make any offer to, or to notify any change in the terms and conditions of appointment of, any new or existing member of staff. If any other member of staff purports to make any offer or effect any change in the terms and conditions of appointment as aforesaid, the University will not be bound by any such offer or change. 18. The University of Sheffield is an equal opportunity employer and has confirmed its commitment to a comprehensive policy of equal opportunities in employment in which individuals are selected and treated on the basis of their relevant merits and abilities. The aim of this policy is to ensure that no job applicant or employee should receive less favourable treatment on any grounds not relevant to good employment practice. The University is committed to a programme of action to make this policy fully effective Ms R A Valerio Director of Human Resource Management 22
  • Appendix 1 The University of Sheffield Department of Human Resources – Personnel Services Payscales for Clinical Academics on the 2003 Consultant Contract TABLE 1: Consultant Senior Lecturers and Consultant Professors CIS Grades AC COSL and AC COPR Threshold / CIS Period before 01-Apr-03 01-Apr-04 01-Apr-05 Increment eligibility for (+ 3.225%) (+ 3.225%) Point threshold* 1 n/a (starting 65,035 67,133 69,298 salary) 2 One year 67,100 69,264 71,498 3 One year 69,165 71,396 73,699 4 One year 71,230 73,528 75,899 5 One year 73,290 75,654 78,094 6 Five years 78,195 80,717 83,320 7 Five years 83,100 85,780 88,547 8 Five years 88,000 90,838 93,768 * Applies only to Clinical Academic staff whose first appointment at the Consultant level was on or after 1 February 2004. Progression for Clinical Academic staff whose first appointment at the Consultant level was on or before 31 January 2004 is set out in Table 3. TABLE 2: Transitional Pay Scale for Consultant Senior Lecturers and Consultant Professors appointed on or before 31 Jan 2004 CIS Grades AC CSLT and AC CPT To be used in conjunction with Table 3 CIS Increment Level of 01-Apr-03 01-Apr-04 01-Apr-05 Point seniority (+ 3.225%) (+ 3.225%) (years) 1 1 65,035 67,133 69,298 2 2 65,550 67,664 69,847 3 3 66,065 68,196 70,395 4 4 66,585 68,733 70,949 5 5 71,230 73,528 75,899 6 6 72,260 74,591 76,996 7 7-29 73,290 75,654 78,094 8 30+ 78,195 80,717 83,320 0* n/a 68,130 70,328 72,596 * Transitional increment point applicable only to staff with 3 years of seniority (see Table 3) 23
  • TABLE 3: Seniority and Thresholds (Transitional Arrangements) Level of Pay Number of years’ Salary for consultants who receive pay Seniority Threshold service before threshold (FTE) (years) eligibility for threshold (since 01-Apr-03 01-Apr-04 01-Apr-05 previous threshold) (+3.225%) (+3.225%) 30+ 7 One year 83,100 85,780 88,547 8 One year 88,000 90,838 93,768 21-29 6 One year 78,195 80,717 83,320 7 One year 83,100 85,780 88,547 8 One year 88,000 90,838 93,768 20 6 One year 78,195 80,717 83,320 7 Two years 83,100 85,780 88,547 8 One year 88,000 90,838 93,768 19 6 One year 78,195 80,717 83,320 7 Two years 83,100 85,780 88,547 8 Two years 88,000 90,838 93,768 18 6 Two years 78,195 80,717 83,320 7 One year 83,100 85,780 88,547 8 Two years 88,000 90,838 93,768 17 6 Two years 78,195 80,717 83,320 7 Two years 83,100 85,780 88,547 8 Two years 88,000 90,838 93,768 16 6 Three years 78,195 80,717 83,320 7 One year 83,100 85,780 88,547 8 Three years 88,000 90,838 93,768 15 6 Three years 78,195 80,717 83,320 7 One year 83,100 85,780 88,547 8 Four years 88,000 90,838 93,768 14 6 Three years 78,195 80,717 83,320 7 Two years 83,100 85,780 88,547 8 Four years 88,000 90,838 93,768 13 6 Three years 78,195 80,717 83,320 7 Two years 83,100 85,780 88,547 8 Five years 88,000 90,838 93,768 12 6 Three years 78,195 80,717 83,320 7 Three years 83,100 85,780 88,547 8 Five years 88,000 90,838 93,768 11 6 Four years 78,195 80,717 83,320 7 Three years 83,100 85,780 88,547 8 Five years 88,000 90,838 93,768 10 6 Four years 78,195 80,717 83,320 7 Four years 83,100 85,780 88,547 8 Five years 88,000 90,838 93,768 9 6 Four years 78,195 80,717 83,320 7 Five years 83,100 85,780 88,547 8 Five years 88,000 90,838 93,768 24
  • Level of Pay Number of years’ Salary for consultants who receive pay Seniority Threshold service before threshold (FTE) (years) eligibility for threshold (since 01-Apr-03 01-Apr-04 01-Apr-05 previous threshold) (+3.225%) (+3.225%) 8 6 Five years 78,195 80,717 83,320 7 Five years 83,100 85,780 88,547 8 Five years 88,000 90,838 93,768 7 6 Five years 78,195 80,717 83,320 7 Five years 83,100 85,780 88,547 8 Five years 88,000 90,838 93,768 6 5 One year 73,290 75,654 78,094 6 Four years 78,195 80,717 83,320 7 Five years 83,100 85,780 88,547 8 Five years 88,000 90,838 93,768 5 * One year 72,260 74,591 76,996 5 One year 73,290 75,654 78,094 6 Four years 78,195 80,717 83,320 7 Five years 83,100 85,780 88,547 8 Five years 88,000 90,838 93,768 4 3 One year 69,165 71,396 73,699 4 One year 71,230 73,528 75,899 5 One year 73,290 75,654 78,094 6 Three years 78,195 80,717 83,320 7 Five years 83,100 85,780 88,547 8 Five years 88,000 90,838 93,768 3 * One year 68,130 70,328 72,596 4 One year 71,230 73,528 75,899 5 One year 73,290 75,654 78,094 6 Four years 78,195 80,717 83,320 7 Five years 83,100 85,780 88,547 8 Five years 88,000 90,838 93,768 2 2 One year 67,100 69,264 71,498 4 One year 71,230 73,528 75,899 5 One year 73,290 75,654 78,094 6 Five years 78,195 80,717 83,320 7 Five years 83,100 85,780 88,547 8 Five years 88,000 90,838 93,768 1 * One year 66,065 68,196 70,395 3 One year 69,165 71,396 73,699 4 One year 71,230 73,528 75,899 5 One year 73,290 75,654 78,094 6 Five years 78,195 80,717 83,320 7 Five years 83,100 85,780 88,547 8 Five years 88,000 90,838 93,768 * For consultants with seniority of 1, 3 or 5 years on transition, the first pay threshold is for transitional purposes. 25